Advertisement
Letter to the Editor|Articles in Press

To the Editor — Maternal inappropriate sinus tachycardia during pregnancy

Open AccessPublished:February 09, 2023DOI:https://doi.org/10.1016/j.hroo.2023.02.001
      Shah and colleagues
      • Shah A.N.
      • Ferreira S.W.
      • Padanilam B.J.
      • Prystowsky E.N.
      Management of inappropriate sinus tachycardia during pregnancy.
      presented 11 patients with maternal inappropriate sinus tachycardia (IST) during pregnancy. Two major points are worth considering.
      First, the authors used a definition for IST consistent with the 2015 Heart Rhythm Society expert consensus statement.
      • Shah A.N.
      • Ferreira S.W.
      • Padanilam B.J.
      • Prystowsky E.N.
      Management of inappropriate sinus tachycardia during pregnancy.
      ,
      • Sheldon R.S.
      • Grubb 2nd, B.P.
      • Olshansky B.
      • et al.
      2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.
      This included a resting heart rate >100 beats/min and an average heart rate >90 beats/min on 24-hour monitoring. Yet, heart rate criteria were derived from nonpregnant individuals. In healthy pregnancy, heart rates >100 beats/min have been observed in more than 10% of subjects from 18 weeks of gestation.
      • Green L.J.
      • Mackillop L.H.
      • Salvi D.
      • et al.
      Gestation-specific vital sign reference ranges in pregnancy.
      Some have suggested that a threshold of 100 beats/min is too low for the upper limit of normal in pregnancy.
      • Coad F.
      • Frise C.
      Tachycardia in pregnancy: when to worry?.
      Maternal IST during pregnancy requires a modification to the present definition. Maintaining the present diagnostic criteria will likely result in overdiagnosis.
      Second, effectiveness and safety of metoprolol succinate remain questionable. Lifestyle modifications, such as increased fluid intake for volume expansion, are often recommended for IST.
      • Sheldon R.S.
      • Grubb 2nd, B.P.
      • Olshansky B.
      • et al.
      2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.
      These alone may improve symptoms. Generally, the performance of β-blockers for IST in nonpregnant patients is considered underwhelming.
      • Olshansky B.
      • Sullivan R.M.
      Inappropriate sinus tachycardia.
      ,
      • Ahmed A.
      • Pothineni N.V.K.
      • Charate R.
      • et al.
      Inappropriate sinus tachycardia: etiology, pathophysiology, and management.
      Moreover, although metoprolol is regarded to be one of the safer β-blockers for use during pregnancy, one study reported low birth weight (<2500 g) in 13.3% of infants with intrauterine exposure to metoprolol compared with 5.2% in nonexposed control subjects.
      • Duan L.
      • Ng A.
      • Chen W.
      • Spencer H.T.
      • Lee M.S.
      Beta-blocker subtypes and risk of low birth weight in newborns.
      There should be caution when considering dose escalation of metoprolol succinate.
      As cardiac electrophysiologists become involved in developing cardio-obstetric teams, it is prudent to be aware that many diagnosis and treatment patterns for nonpregnant patients may need to be adjusted for pregnant patients.

      Funding Sources

      The author has no funding sources to disclose.

      Disclosures

      The author has no conflicts to disclose.

      Authorship

      The author attests he meets the current ICMJE criteria for authorship.

      References

        • Shah A.N.
        • Ferreira S.W.
        • Padanilam B.J.
        • Prystowsky E.N.
        Management of inappropriate sinus tachycardia during pregnancy.
        Heart Rhythm O2. 2023; 4: 65-66
        • Sheldon R.S.
        • Grubb 2nd, B.P.
        • Olshansky B.
        • et al.
        2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.
        Heart Rhythm. 2015; 12: e41-e63
        • Green L.J.
        • Mackillop L.H.
        • Salvi D.
        • et al.
        Gestation-specific vital sign reference ranges in pregnancy.
        Obstet Gynecol. 2020; 135: 653-664
        • Coad F.
        • Frise C.
        Tachycardia in pregnancy: when to worry?.
        Clin Med. 2021; 21: e434-e437
        • Olshansky B.
        • Sullivan R.M.
        Inappropriate sinus tachycardia.
        Europace. 2019; 21: 194-207
        • Ahmed A.
        • Pothineni N.V.K.
        • Charate R.
        • et al.
        Inappropriate sinus tachycardia: etiology, pathophysiology, and management.
        J Am Coll Cardiol. 2022; 79: 2450-2462
        • Duan L.
        • Ng A.
        • Chen W.
        • Spencer H.T.
        • Lee M.S.
        Beta-blocker subtypes and risk of low birth weight in newborns.
        J Clin Hypertens (Greenwich). 2018; 20: 1603-1609

      Linked Article

      • Reply to the Editor — Maternal inappropriate sinus tachycardia during pregnancy
        Heart Rhythm O2
        • Preview
          We would like to comment on the letter by Wang on our article.1 He acknowledges that we used the standard accepted definition of inappropriate sinus tachycardia (IST) but raises the issue of whether an alternative definition of IST should be used during pregnancy. Indeed, recent data in pregnant women show that the median heart rate was 82 beats/min at 12 weeks’ gestation and rose to 91 beats/min at 34.1 weeks.2 However, the average heart rates in our patients, mostly recorded in the early second trimester, were typically more than 100 beats/min, and more importantly, they were highly symptomatic with the added history of rapid and marked increases in heart rate during exertion, a classic presentation of IST.
        • Full-Text
        • PDF
        Open Access